Correlation between the rate of intravitreal injections, use of aflibercept as a second-line treatment and visual impairment for wet AMD in Finland.

Acta ophthalmologica(2020)

引用 3|浏览20
暂无评分
摘要
These results emphasize that the use of aflibercept injections as a second-line treatment may decrease new onset visual impairments.
更多
查看译文
关键词
aflibercept,anti-vascular endothelial growth factor,treat-and-extend regimen,visual impairment,wet age-related macular degeneration
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要